GalenusRx
PrivateLast Round
Grant
Oct 17, 2025
Total Funding Raised
$9.88M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GalenusRx is a healthcare technology company that provides a medication safety platform, APPRAISE, which analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to provide a comprehensive risk assessment.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GalenusRx Comparables
Compare GalenusRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DecisionRx | 91% | |
| MDI Health | 85% | |
| FeelBetter | 84% |
GalenusRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 17, 2025 | ||||
| Series A | Jul 17, 2024 |
Key People
Founding team and executive leadership
GalenusRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 37% MoM, reaching 2.1K.
- May 19, 2026
Monthly visitors increased 33% MoM.
GalenusRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access